Sensus Healthcare, Inc.

NASDAQ:SRTS

Medical - Devices

Healthcare
$3.22 +3.05%

+$0.09 today

Market cap
$53.01M
Beta
1.09
P/E (TTM)
-6.5
EPS (TTM)
-$0.47
52W Low $2.66High $5.92

Volume 0.08M

Average 0.06M

SRTS Deferred Revenue

Payments received for goods or services the company will deliver within the next year.

Sensus Healthcare, Inc.NASDAQ: SRTS

Deferred Revenue · Q1 FY2026 · quarter ended Mar 2026

Deferred revenue rises 16.2% from a year ago

Deferred revenue stood at $639K at the end of Q1 FY2026, up 16.2% from a year earlier and down 24.1% from the prior quarter. Over 3 fiscal years it compounded at +6.7% a year.

Context

  • Deferred revenue amounted to 1.2% of total assets at the end of Q1 FY2026, up 0.3 pp from a year earlier.
  • Deferred revenue increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether deferred revenue keeps rising in the next quarterly balance sheet after a +16.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$639K-24.1% QoQ
Last fiscal yearDec 2025
$842K+55.6% YoY
Year agoMar 2025
$550K+16.2% since
Deferred Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+16.2%——
1 year+55.6%——
3-year CAGR+6.7%——
5-year CAGR——
10-year CAGR——

Deferred Revenue history

USD · from the balance sheet

Latest · FY2025
842K USD
Year-over-year change
+55.6%
4-year CAGR
-7.9%

Deferred Revenue vs competitors

How SRTS compares with its peers on the latest reported figures

  • SRTS's Mar 2026 deferred revenue of $639K is the 2nd highest of the 6 companies compared; the peer median is $0.
  • Its year-over-year change of +16.2% is the highest of 3, against a peer median of -49.9%.
  • Deferred revenue amounts to 1.2% of total assets for SRTS, versus a peer median of 0.0%.
SRTS Competitors Peer median
Deferred Revenue for SRTS and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
BDMDBaird Medical Investment Holdings LimitedDec 2025$793.41K +0.2%+4.6%1.1%
SRTSSensus Healthcare, Inc.Mar 2026$639K +16.2%+6.7%1.2%
IPSCCentury Therapeutics, Inc.Mar 2026$0 ——0.0%
MDAISpectral AI, Inc.Mar 2026$0 -100.0%—0.0%
TELATELA Bio, Inc.Jun 2026$0 ——0.0%
KPTIKaryopharm Therapeutics Inc.Mar 2026$0 ——0.0%
Peer median (excluding SRTS) $0-49.9%+4.6%0.0%

Competitors are the stored peer set for SRTS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents14.52M25.52M23.15M22.06M22.08M
Short-term Investments00000
Net Receivables12.13M17.3M10.65M19.73M6.04M
Inventory1.76M3.5M11.86M10.1M14.56M
Other Current Assets268K660K888K1.51M1.68M
Total Current Assets31.25M53.24M49.53M56.74M45.89M
Property, Plant & Equipment (Net)774K1.24M1.24M2.58M2.43M
Goodwill00000
Intangible Assets146K50K000
Long-term Investments00000
Tax Assets01.71M2.14M2.2M4.08M
Other Non-current Assets75K492K804K652K640K
Total Non-current Assets995K3.49M4.18M5.43M7.15M
Total Assets32.24M56.74M53.71M62.17M53.04M
Account Payables4.06M5.52M2.79M4.81M3.34M
Short-term Debt51K000262K
Tax Payables0890K37K00
Deferred Revenue1.17M693K657K541K842K
Other Current Liabilities508K403K538K329K275K
Total Current Liabilities5.96M7.7M4.21M5.89M4.72M
Long-term Debt0000209K
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)262K139K60K55K10K
Other Non-current Liabilities0000(209K)
Total Non-current Liabilities262K969K656K453K219K
Total Liabilities6.23M8.67M4.87M6.34M4.94M
Common Stock167K169K169K169K169K
Retained Earnings(17.94M)6.3M6.79M13.43M5.72M
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity26.02M48.07M48.84M55.83M48.1M
Total Debt225K1.02M783K602K680K
Net Debt(14.29M)(24.5M)(22.37M)(21.45M)(21.4M)

Sensus Healthcare, Inc.

NASDAQ:SRTS

Intrinsic Alpha fair value

Locked

Current Price

$3.22

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.